Invesaro

Stocks ZD Financial statements

Financial statements

ZIFF DAVIS, INC. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data ZIFF DAVIS, INC. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue8741,1181,2071,0501,1591,4171,3911,3641,4021,451
Cost of revenue147172201187178188185186200207
Gross profit7279461,0068639801,2291,2061,1781,2011,245
Research and development384648.444.757.178.974.168.967.462
Selling and marketing207330338328366493491487520543
General and administrative240324375403419457182196203210
Operating expenses4857007627758421,061
Operating income24324624488.2138167199133114183
Interest expense42.759.263.526.158.179.637.141.635.337.6
Other non-operating income10.222-4.63-2.310.071.298.44-9.474.97-5.89
Pre-tax income21120017854.878.33511317593.280.7
Income tax5960.544.813.838.4-14.25824.141.425.4
Income from continuing operations40.928.740165.541.56347.4
Net income15213912921915149763.841.56347.4
EBITDA365408431320367426432370326412
EPS, basic3.152.892.644.523.2410.811.360.891.421.16
EPS, diluted3.132.832.594.393.1810.371.360.891.421.15
Shares, basic (weighted)47.747.64847.646.345.94746.444.541
Shares, diluted (weighted)4848.748.94947.147.94746.544.541.1
Dividend per share1.361.521.680.900.000.00

Balance sheet

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash and equivalents124351209576176695653738506574
Short-term investments0.0600.6622958.427.10
Receivables200234222262310316305338660623
Other current assets24.235.329.249.352.260.368.388.610682
Total current assets3486204608876231,3011,0841,1911,2721,370
Property, plant and equipment68.179.898.8128132161178188197162
Lease right-of-use assets012680.155.640.624.626.222.3
Goodwill1,1231,1971,3801,3131,5251,5311,5911,5461,5801,347
Intangible assets479453495525697573463325426338
Long-term investments057.783.810097.512312814115893.2
Other non-current assets6.4512.81115.715.875.780.170.863.424.5
Total assets2,0622,4532,5613,5063,6653,7703,5333,4713,7043,663
Accounts payable178170167238198131121123164145
Accrued liabilities54.642.250.155.831.3
Deferred revenue80.495.3128163166186188185200130
Short-term debt00038639754.600149
Total current liabilities4542653078338834974324329001,075
Long-term debt6021,0021,0131,0631,1821,0369991,001864718
Lease liabilities010473.653.73416.621.817.8
Other non-current liabilities3.4831.451.110.241.491.36946.747.733.1
Total liabilities1,1481,4331,5252,1952,4541,8031,6411,5781,8931,910
Total debt6021,0021,0131,4481,5791,0919991,001864867
Paid-in capital308326354466456509440472492473
Retained earnings6607237708928091,5151,5381,4921,4011,338
Treasury stock0-42.500
Other comprehensive income-54.6-29.1-46-46.5-54.8-57.2-85.4-71.6-82.5-57.1
Shareholders' equity9151,0201,0361,3111,2111,9681,8931,8931,8111,754
Total equity9151,0201,0361,3111,2111,9681,8931,8931,8111,754
Total liabilities and equity2,0622,4532,5613,5063,6653,7703,5333,4713,7043,663
Shares outstanding47.447.947.547.744.347.447.346.142.838.4

Cash flow statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Net income15213912921915149763.841.56347.4
Depreciation and amortization122162187232229258233237212229
Stock-based compensation13.722.728.123.92425.226.631.940.944.9
Deferred income tax-13.8-21.425.1-7.510.31-21.4-13-30-18.83.96
Change in receivables-30.7-37.54.03-30.7-31.6-18.114.9-35.4-153-8.38
Change in payables6.36-34.1-35.2-0.772.180.48-20.29.42171
Cash from operations282264401413480517336320390407
Capital expenditures-24.7-39.6-56.4-70.6-92.6-114-106-109-107-119
Acquisitions-581-175-312-415-482-141-104-9.49-218-67.3
Purchases of investments-80.9-0-0.5000-1500
Sales and maturities of investments24200000.6600
Cash from investing-449-158-407-505-58659.1-221-127-297-146
Debt issued0650055075000
Debt repaid0-255-2.2-5.1-650-512-1670-1350
Stock issued3.571.111.545.271.622.940.1500
Share buybacks-56.5-9.85-47.1-20.8-276-78.3-78.3-109-185-174
Dividends paid-65.8-73.5-82.6-43.900
Cash from financing41.2112-131457-235-113-141-115-321-170
Exchange rate effect-6.269.24-4.822.187.81-10.3-16.97.06-3.6
Net change in cash-132227-141366-333452-4284.8-232101
Free cash flow258225345342388403230211284288
Interest paid33.135.85455.410654.536.238.728.934.6
Income taxes paid37.451.137.645.94561.259.564.668.748.6

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $56.51 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin86.1%Gross profit / revenue.
Operating margin7.9%Operating income / revenue.
EBITDA margin22.6%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin-1.8%Pre-tax income / revenue.
Net margin44.7%Net income / revenue.
FCF margin22.0%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin31.2%Cash from operations / revenue.
Return on equity (ROE)28.8%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)16.1%Net income / average total assets.
Return on invested capital (ROIC)6.0%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue4.0%Research and development expense / revenue.
Stock-based pay / revenue3.2%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue9.1%Capital expenditures / revenue.
D&A / revenue14.7%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y3.5%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y1.4%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y4.6%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y3.6%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y1.0%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y4.9%Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y61.1%Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y-2.7%Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y5.8%Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y26.5%EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y-1.6%Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y2.3%Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y-24.9%Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y-9.4%Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y-20.7%Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y-19.0%EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y-5.4%Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y-18.4%Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y4.3%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y6.6%Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y-3.2%Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y1.5%Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y7.7%Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y-5.8%Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y-3.2%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y-2.5%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y7.7%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y-1.1%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y1.2%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y-0.0%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y-7.7%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y-4.4%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y-2.7%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio2.16xCurrent assets / current liabilities.
Quick ratio2.10x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio1.67x(Cash + short-term investments) / current liabilities.
Debt / equity0.39xTotal debt / shareholders' equity. Not shown when equity is negative.
Debt / assets21.7%Total debt / total assets.
Liabilities / assets44.0%Total liabilities / total assets.
Net debt-$738.5MTotal debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA-2.27xNet debt / EBITDA (twelve months), when EBITDA is positive.
Working capital$1.12BCurrent assets - current liabilities.
Goodwill and intangibles / assets39.6%(Goodwill + intangible assets) / total assets.
Tangible book value$652.7MShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover0.36xRevenue / average total assets.
Fixed asset turnover8.39xRevenue / average property, plant and equipment.
Receivables turnover3.43xRevenue / average receivables.
Days sales outstanding106 days365 x average receivables / revenue.
Days payables266 days365 x average accounts payable / cost of revenue.
FCF conversion49.2%Free cash flow / net income, when net income is positive.
Capex / operating cash flow29.3%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted$17.69Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$39.53Revenue / diluted weighted shares.
FCF per share$8.71Free cash flow / diluted weighted shares.
Operating cash flow per share$12.32Cash from operations / diluted weighted shares.
Book value per share$64.00Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share$18.67Tangible book value / shares outstanding.
Cash per share$45.94(Cash + short-term investments) / shares outstanding.
Buybacks / FCF87.8%Share buybacks / free cash flow, when free cash flow is positive.

Valuation

MetricValueHow it is calculated
Market cap$1.94BShare price x shares outstanding.
Enterprise value$1.20BMarket cap + total debt - cash - short-term investments.
P/E3.01xMarket cap / net income. Only when net income is positive.
P/S1.35xMarket cap / revenue.
P/B0.87xMarket cap / shareholders' equity. Only when equity is positive.
Price / tangible book2.97xMarket cap / tangible book value, when positive.
P/FCF6.12xMarket cap / free cash flow. Only when free cash flow is positive.
P/OCF4.32xMarket cap / cash from operations, when positive.
EV/Sales0.83xEnterprise value / revenue.
EV/EBIT10.6xEnterprise value / operating income, when both are positive.
EV/EBITDA3.69xEnterprise value / EBITDA, when both are positive.
EV/FCF3.79xEnterprise value / free cash flow, when both are positive.
FCF yield16.3%Free cash flow / market cap.
Earnings yield33.2%Net income / market cap (the inverse of P/E).
Shareholder yield14.3%(Dividends paid + share buybacks) / market cap.
What was ZIFF DAVIS, INC.'s revenue in fiscal 2025?

ZIFF DAVIS, INC. reported revenue of $1.45B for fiscal 2025, 3.5% higher than the year before.

Was ZIFF DAVIS, INC. profitable in fiscal 2025?

Yes. Net income was $47.4M, a net margin of 3.3%.

How much free cash flow did ZIFF DAVIS, INC. generate in fiscal 2025?

Cash from operations of $407.1M minus capital expenditures of $119.2M left free cash flow of $287.9M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to ZIFF DAVIS, INC.